Comparison of (68)Ga-PSMA PET/CT and (18)F-PSMA PET/CT of a Patient with Prostate Cancer Recurrence on Urinary Bladder Wall.
Molecular imaging and radionuclide therapy, cilt.32, sa.2, ss.150-152, 2023 (ESCI, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 32 Sayı: 2
- Basım Tarihi: 2023
- Doi Numarası: 10.4274/mirt.galenos.2023.47550
- Dergi Adı: Molecular imaging and radionuclide therapy
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.150-152
- Anahtar Kelimeler: Cancer, prostate, positron emission tomography, Ga-68-PSMA, F-18-PSMA
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Ankara Üniversitesi Adresli: Evet
Özet
Prostate cancer is one of the most prevalent cancers in the world. After radical prostatectomy, prostate-specific antigen (PSA) levels are usually used as a marker of recurrence for prostate cancer. In the case of increased PSA levels,68Ga-prostate-specific membrane antigen (PSMA) or 18 F-PSMA, a new alternative, can be performed for the detection of recurrent disease. We report a case of a 49-year-old male patient with increasing PSA levels who was previously operated 8 years ago. Although no obvious pathological uptake was detected in68Ga-PSMA positron emission tomography/computed tomography (PET/CT),18F-PSMA PET/CT revealed a lesion with pathological uptake on the urinary bladder wall.